Care for 40 Pregnant Women Who Tested Positive for COVID-19 by PCR at Our Hospital

DOI Web Site Web Site
  • ANDO Mikiko
    Dept. of Obstetrics and Gynecology, JA Toride Medical Center
  • MOMOHARA Yoshihito
    Dept. of Obstetrics and Gynecology, JA Toride Medical Center
  • SHIMADA Michi
    Dept. of Perinatal and Women's Medicine, Tokyo Medical Dental University
  • ISHIKAWA Ikuno
    Dept. of Obstetrics and Gynecology, JA Toride Medical Center
  • SEGA Masayasu
    Dept. of Obstetrics and Gynecology, JA Toride Medical Center
  • KURATOMI Yuri
    Dept. of Obstetrics and Gynecology, JA Toride Medical Center
  • ONOSE Moeko
    Dept. of Obstetrics and Gynecology, JA Toride Medical Center
  • YATABE Natsuki
    Dept. of Obstetrics and Gynecology, JA Toride Medical Center
  • AKITA Mayu
    Dept. of Obstetrics and Gynecology, JA Toride Medical Center
  • UMEKI Hidenori
    Dept. of Obstetrics and Gynecology, JA Toride Medical Center

Bibliographic Information

Other Title
  • 当院におけるCOVID-19 PCR陽性妊婦40例の対応
  • トウ イン ニ オケル COVID-19 PCR ヨウセイ ニンプ 40レイ ノ タイオウ

Search this article

Abstract

Our hospital is a designated medical institution for class 1 infectious diseases and a regional perinatal medical center where infants at 35 weeks of gestation or older can be delivered. We examined 40 pregnant women who tested positive for COVID-19 by PCR who visited our hospital. Two were in the first trimester, 7 in the second trimester, and 31 in the third trimester of pregnancy (18 at 37 weeks or later). Initially, all pregnant women who tested positive were hospitalized, but from August 2021, some were allowed to recover at home when they had mild COVID-19 or pregnancy was earlier than 37 weeks of gestation. In 28 hospitalized women, 10 gave birth at our hospital (1 by cesarean section and 9 by vaginal delivery). Pregnancy was ended early in response to COVID-19 in 3 cases, specifically, 1 by emergency cesarean section, 1 by emergency cesarean section at another hospital because of the timing (34 weeks), and 1 by induction of labor followed by vaginal delivery. Therapeutic intervention was provided in 5 cases (prednisolone in 4, heparin in 3, and both prednisolone and heparin in 2 cases). There were no cases of secondary infections of healthcare providers. Therapeutic intervention alleviated symptoms in some cases, suggesting that vaginal delivery can be an option for pregnant women with COVID-19 depending on COVID-19 symptoms and obstetric indications.

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top